US › Healthcare

Optimi Health Corp. Common Shares (OPTH)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$3.38+5.96%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$98,700

Revenue YoY

-49.7%

Net profit

$-1.7M

EPS

$-0.40

EPS estimate

$-0.26

Net margin

-1,715.0%

EPS came in at -0.40 against a street estimate of -0.26 — a miss of 53.8%.

Key statistics

Market cap

$18.3M

Forward P/E

0.0

P/B

2.26

Book value

$2.17

EPS (TTM)

$-1.56

52-week high

$8.84

52-week low

$3.04

50-day MA

$4.67

200-day MA

$4.77

Beta

1.57

Shareholding

Insiders

12.66%

Institutions

7.29%

Largest institutional holders

Fund	Stake
Yorkville Advisors Global, LP	3.48%
Mariner Wealth Advisors LLC	2.13%
AdvisorShares Investments, LLC	1.80%
TWO SIGMA SECURITIES, LLC	0.18%
UBS Group AG	0.10%
Royal Bank of Canada	0.03%
NATIONAL BANK OF CANADA /FI/	0.01%
TD Waterhouse Canada Inc	0.01%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Optimi Health Corp. Common Shares — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.